ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1146

Study of Vertebral and Femur Fracture Prevalence and Scanographic Bone Attenuation Coefficient of the First Lumbar Vertebra in an Academic Hospital Setting

Zareen Vaghaiwalla1, Paul Wasserman1 and Gurjit Kaeley2, 1University of Florida College of Medicine Jacksonville, Jacksonville, FL, 2University of Florida, Jacksonville, FL

Meeting: ACR Convergence 2021

Keywords: Bone density, Computed tomography (CT), Dual energy x-ray absorptiometry (DEXA), osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster (1135–1149)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Patients with osteoporosis are prone to suffer fragility fractures leading to an increased risk of future fractures. Detection of osteoporosis has been led by dual energy-ray absorptiometry (DEXA) as the gold standard. However, in acute fracture incidents, DEXA imaging is typically unavailable, and treatment is often delayed. In recent years scanographic bone attenuation coefficient of the first (SBAC-L1) on incidental computed tomography (CT) scans of the lumbar spine has been utilized as an alternative assessment of bone density. In particular, SBAC-L1 ≤ 145 HU correlates with osteoporotic bone density on DEXA imaging.

This study aims to assess the SBAC-L1 in HU of incidental CT scans in patients presenting with vertebra or femur fragility fractures in an academic hospital as it relates to osteoporosis.

Methods: We conducted a retrospective chart review of patients aged ≥ 45 admitted to an academic hospital for active vertebral or femur fracture between 1/1/2017- 1/31/2019, excluding traumatic and pathological fractures. Measurement of SBAC-L1 in HU was obtained on incidental CT scan imaging. Sex, race, prior and post diagnoses of osteoporosis, prior and post DEXA scan orders, use of calcium, vitamin D, and steroids were abstracted.

Results: There were 297 patients with vertebral or femur fractures from 1/1/2017- 1/31/2019. Of 297 patients, 85 deemed appropriate after excluding pathological, traumatic fractures, and lack of CT scan on the admission for fracture.

Average SBAC-L1 for all patients was 100.4 ± standard deviation (SD) of 46.5 HU. 82% of all patients had SBAC-L1 ≤ 145 HU. Caucasian patients had a lower average SBAC-L1 [99.4 HU] than African American (AA) patients [122.1 HU]. More Caucasian [n=15] had prior diagnoses of osteoporosis than AA [n=2]. Caucasian patients were prescribed Calcium and Vitamin D more often [n=39] than AA [n=3]. DEXA scan orders were placed more often in Caucasian patients [n=4] than AA patients [n=1]. Osteoporosis medications were prescribed more often in Caucasian patients [n=8] than AA patients [n=0].

Male average SBAC-L1 was 97.4 HU compared to females at 106.3 HU. Females were prescribed calcium and vitamin D more often [n=38] than males [n=8]. DEXA scan orders were placed more frequently in females [n=5] than males [n=2]. Osteoporosis medications were prescribed more often in females [n=9] than male patients [n=0].

Conclusion: 70 of 85 patients with incidental fragility fractures exhibited SBAC-L1 ≤ 145 HU. This is consistent with osteoporotic bone density on DEXA imaging supporting the use of SBAC-L1 measurement to corroborate the diagnosis osteoporosis. SBAC-L1 ≤ 145 HU can be utilized to increase inpatient diagnostic confidence of osteoporosis in the setting of acute fragility fractures to allow initiation of treatment prior to awaiting outpatient DEXA imaging.

The results here also highlight health disparities present among African Americans and males of all races when considering bone health.

Study Characteristics

Comparison in Age for African American (AA) patients and Caucasian (C) patients

SBAC- L1 (HU) in African American (AA) and Caucasian ( C) races


Disclosures: Z. Vaghaiwalla, None; P. Wasserman, None; G. Kaeley, Novartis, 2.

To cite this abstract in AMA style:

Vaghaiwalla Z, Wasserman P, Kaeley G. Study of Vertebral and Femur Fracture Prevalence and Scanographic Bone Attenuation Coefficient of the First Lumbar Vertebra in an Academic Hospital Setting [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/study-of-vertebral-and-femur-fracture-prevalence-and-scanographic-bone-attenuation-coefficient-of-the-first-lumbar-vertebra-in-an-academic-hospital-setting/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/study-of-vertebral-and-femur-fracture-prevalence-and-scanographic-bone-attenuation-coefficient-of-the-first-lumbar-vertebra-in-an-academic-hospital-setting/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology